NCT05266534Recruiting
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets
The Effect of Intramyometrial Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Open Myomectomy Operations Without Using Haemostatic Tourniquets.
Source: ClinicalTrials.gov · Last updated 4 Mar 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
For gynecologists, reaching a conclusion about the efficacy of intramyometrial Terlipressin injection versus intramyometrial Carbetocin injection on hemoglobin level and decreasing blood loss in women undergoing open myomectomy that would influence the clinical decision and best practice. Besides enriching the clinical evidence in open myomectomy without using haemostatic tourniquets. For society, our conclusion and recommendation shall maximize the benefits and managing the benefits of the technique used. Moreover, providing more information for women undergoing open myomectomy without using haemostatic tourniquets.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 162 (estimated)
- First submitted
- 21 Dec 2021
- Start date
- 30 Dec 2021
- Primary completion date
- 30 Jun 2024
- Lead sponsor
- Wael Elbanna Clinic
- NCT number
- NCT05266534
What you commit to
- Study type: Interventional
- Planned participants: 162
- From 30 Dec 2021 to the primary completion date, 30 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous myomectomy
- Concurrent anticoagulation therapy
- Any pelvic abnormalities requiring concomitant surgery
- Treatment with a GnRH agonist or ulipristal acetate within three months preceding surgery
Other illness
- History of bleeding disorders
- History of Uncontrolled ischaemic heart disease
Other
- Open myomectomy using mechanical tourniquet
- Inability to understand and provide written informed consent
Criteria the registry did not label
- Inclusion Criteri
- Women aged 16-45 yearsAppropriate medical status for open surgery (Largest Myoma size from 4 cm up to 20 cm)
- Baseline hemoglobin ≥9 g/dl
- No contra-indications to the use of glyopressin or carbitocin
- Myoma-related symptoms, such as pelvic pressure or pain,menorrhagia, or infertility
- Not pregnant at the time of presentation (i.e., negative urine pregnancy test or last menstrual period within the last 4 weeks)
Age in the registry: 16 years to 40 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wael El Banna Clinic Coordinator of this site? Confirm its status | Maadi | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.